Gnai2/gip2-regulated transcriptome and its therapeutic significance in ovarian cancer

Keyphrases

• Transcriptome 100%
• Ovarian Cancer 100%
• Ovarian Cancer Cells 100%
• Therapeutic Significance 100%
• G Protein 33%
• Adhesion 33%
• Oncogene 33%
• Acid Activation 33%
• Gene Coding 33%
• Cell Proliferation 33%
• Growth Factors 33%
• Short Hairpin RNA (shRNA) 33%
• Microarray 33%
• Array-based 33%
• Cellular Response 33%
• Vascular Endothelial Growth Factor 33%
• Multifunctional Protein 33%
• Functional Annotation 33%
• Bioinformatics Analysis 33%
• Transcriptome Analysis 33%
• CCL20 33%
• Novel Therapeutics 33%
• Changes in Gene Expression 33%
• Cell Therapy 33%
• Cellular Metabolism 33%
• Cancer Pathogenesis 33%
• SKOV3 33%
• Lysophosphatidic Acid Receptor 33%
• Lysophosphatidic Acid 33%
• DAVID 33%
• OVCAR-3 33%
• Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) 33%
• Therapy Resistance 33%
• Stage Progression 33%
• Multi-modular 33%
• High-grade Serous Ovarian Cancer (HGSOC) 33%
• Gene Set Enrichment Analysis 33%
• Bottleneck Node 33%
• Transcriptomic Network 33%
• Cytoscape 33%
• Hub Nodes 33%
• COX5B 33%
• CXCR7 33%
• UQCRC1 33%
• ACKR3 33%
• UQCRFS1 33%
• Modular Networks 33%

Biochemistry, Genetics and Molecular Biology

• Transcriptome 100%
• Cancer Cell 66%
• Transcriptomics 66%
• Lysophosphatidic Acid 66%
• Proto Oncogene 33%
• Upregulation 33%
• Cell Proliferation 33%
• Gene Expression 33%
• Microarrays 33%
• Cell Metabolism 33%
• Small Hairpin RNA 33%
• Bioinformatics Software 33%
• Gene Set Enrichment Analysis 33%
• FYN 33%
• CCL20 33%
• CXCR7 33%
• G Protein 33%
• Vasoactive Intestinal Peptide 33%